drugset / Trial / NCT00337558

A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)

NCT00337558

RandomizedParallel-groupOpen-labelTreatment

Summary

This study will look at a drug for OAB (solifenacin) in combination with a non drug treatment (bladder training) compared to the drug on its own. The study will compare the symptoms of OAB by assessing patient diaries and other patient reported outcomes.

Timeline

Start
2006-05
Primary completion
2007-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Solifenacin Small molecule 5 mg
Subject Solifenacin Small molecule 10 mg

Indications